Brca1 Mutation Carrier Completed Phase 1 Trials for Carboplatin (DB00958)

Also known as: BRCA1 Mutation Carrier

IndicationStatusPhase
DBCOND0030677 (Brca1 Mutation Carrier)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01251874Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast CancerTreatment
NCT00535119Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid CancerTreatment